Percutaneous vertebroplasty for osteoporotic vertebral compression fractures in the nonagenarians: A prospective study evaluating pain reduction and new symptomatic fracture rate

Michael J. Depalma, Jessica M. Ketchum, Bruce M. Frankel, Michael E. Frey

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Study Design. A prospective observational cohort study of consecutive osteoporotic vertebral compression fractures (VCFs) in ≥90-year-old patients evaluated at a multidisciplinary, university spine center. Objective. Assess efficacy, safety, and new fracture occurrence after percutaneous vertebroplasty (PV) in a large uncontrolled cohort of ultra elderly VCF patients. Summary Of Background Data. VCFs are associated with increased morbidity and mortality. Percutaneous injection of polymethylmethacryl-ate into the fractured vertebral body, vertebroplasty, has been extensively performed as an effective minimally-invasive treatment option for VCF patients. The patient sample included consecutive, osteoporotic patients with symptomatic VCFs electing to enter the study. Methods. Baseline visual analogue scale rating, analgesic usage, duration of symptoms. Subsequent VAS ratings, analgesic utilization, and new fractures were assessed within 30 minutes after the procedure, at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years postprocedure. Outcome measures: Visual Analogue Scale score, analgesic utilization, patient satisfaction, cement extravasation, and new fractures. Results. A total of 123 (74% female) underwent PV for 163 VCFs. Eleven patients did not complete final follow-up at 2 years due to death unrelated to the PV procedure. The mean VAS score was 7.6 at baseline and 3.1 at 30 minutes after the procedure, and 2.3, 1.2, 1.1, 0.9, 0.8, and 0.5 at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years, respectively. Improvement over time was statistically significant using repeated measures analysis of variance (P < 0.05). No complications were encountered during the follow-up intervals. Thirteen new fractures were observed (10.6%) at a mean 20.8 weeks (1-52 weeks) after PV with 6 new fractures (4.9%) involving an adjacent level in 5 patients (4.1%). Conclusion. Vertebroplasty for VCFs in the very elderly appears effective and safe without increased risk of adjacent level fracture.

Original languageEnglish (US)
Pages (from-to)277-282
Number of pages6
JournalSpine
Volume36
Issue number4
DOIs
StatePublished - Feb 15 2011

Fingerprint

Vertebroplasty
Compression Fractures
Prospective Studies
Pain
Analgesics
Visual Analog Scale
Patient Satisfaction
Observational Studies
Analysis of Variance
Spine
Cohort Studies
Outcome Assessment (Health Care)
Morbidity
Safety
Injections
Mortality

Keywords

  • low back pain
  • osteoporosis
  • recurrent fracture
  • vertebral fracture
  • vertebroplasty

ASJC Scopus subject areas

  • Clinical Neurology
  • Orthopedics and Sports Medicine

Cite this

Percutaneous vertebroplasty for osteoporotic vertebral compression fractures in the nonagenarians : A prospective study evaluating pain reduction and new symptomatic fracture rate. / Depalma, Michael J.; Ketchum, Jessica M.; Frankel, Bruce M.; Frey, Michael E.

In: Spine, Vol. 36, No. 4, 15.02.2011, p. 277-282.

Research output: Contribution to journalArticle

Depalma, Michael J. ; Ketchum, Jessica M. ; Frankel, Bruce M. ; Frey, Michael E. / Percutaneous vertebroplasty for osteoporotic vertebral compression fractures in the nonagenarians : A prospective study evaluating pain reduction and new symptomatic fracture rate. In: Spine. 2011 ; Vol. 36, No. 4. pp. 277-282.
@article{c653ca5fbb624203a0fe9e4648bcf95d,
title = "Percutaneous vertebroplasty for osteoporotic vertebral compression fractures in the nonagenarians: A prospective study evaluating pain reduction and new symptomatic fracture rate",
abstract = "Study Design. A prospective observational cohort study of consecutive osteoporotic vertebral compression fractures (VCFs) in ≥90-year-old patients evaluated at a multidisciplinary, university spine center. Objective. Assess efficacy, safety, and new fracture occurrence after percutaneous vertebroplasty (PV) in a large uncontrolled cohort of ultra elderly VCF patients. Summary Of Background Data. VCFs are associated with increased morbidity and mortality. Percutaneous injection of polymethylmethacryl-ate into the fractured vertebral body, vertebroplasty, has been extensively performed as an effective minimally-invasive treatment option for VCF patients. The patient sample included consecutive, osteoporotic patients with symptomatic VCFs electing to enter the study. Methods. Baseline visual analogue scale rating, analgesic usage, duration of symptoms. Subsequent VAS ratings, analgesic utilization, and new fractures were assessed within 30 minutes after the procedure, at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years postprocedure. Outcome measures: Visual Analogue Scale score, analgesic utilization, patient satisfaction, cement extravasation, and new fractures. Results. A total of 123 (74{\%} female) underwent PV for 163 VCFs. Eleven patients did not complete final follow-up at 2 years due to death unrelated to the PV procedure. The mean VAS score was 7.6 at baseline and 3.1 at 30 minutes after the procedure, and 2.3, 1.2, 1.1, 0.9, 0.8, and 0.5 at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years, respectively. Improvement over time was statistically significant using repeated measures analysis of variance (P < 0.05). No complications were encountered during the follow-up intervals. Thirteen new fractures were observed (10.6{\%}) at a mean 20.8 weeks (1-52 weeks) after PV with 6 new fractures (4.9{\%}) involving an adjacent level in 5 patients (4.1{\%}). Conclusion. Vertebroplasty for VCFs in the very elderly appears effective and safe without increased risk of adjacent level fracture.",
keywords = "low back pain, osteoporosis, recurrent fracture, vertebral fracture, vertebroplasty",
author = "Depalma, {Michael J.} and Ketchum, {Jessica M.} and Frankel, {Bruce M.} and Frey, {Michael E.}",
year = "2011",
month = "2",
day = "15",
doi = "10.1097/BRS.0b013e3181cf8a37",
language = "English (US)",
volume = "36",
pages = "277--282",
journal = "Spine",
issn = "0362-2436",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Percutaneous vertebroplasty for osteoporotic vertebral compression fractures in the nonagenarians

T2 - A prospective study evaluating pain reduction and new symptomatic fracture rate

AU - Depalma, Michael J.

AU - Ketchum, Jessica M.

AU - Frankel, Bruce M.

AU - Frey, Michael E.

PY - 2011/2/15

Y1 - 2011/2/15

N2 - Study Design. A prospective observational cohort study of consecutive osteoporotic vertebral compression fractures (VCFs) in ≥90-year-old patients evaluated at a multidisciplinary, university spine center. Objective. Assess efficacy, safety, and new fracture occurrence after percutaneous vertebroplasty (PV) in a large uncontrolled cohort of ultra elderly VCF patients. Summary Of Background Data. VCFs are associated with increased morbidity and mortality. Percutaneous injection of polymethylmethacryl-ate into the fractured vertebral body, vertebroplasty, has been extensively performed as an effective minimally-invasive treatment option for VCF patients. The patient sample included consecutive, osteoporotic patients with symptomatic VCFs electing to enter the study. Methods. Baseline visual analogue scale rating, analgesic usage, duration of symptoms. Subsequent VAS ratings, analgesic utilization, and new fractures were assessed within 30 minutes after the procedure, at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years postprocedure. Outcome measures: Visual Analogue Scale score, analgesic utilization, patient satisfaction, cement extravasation, and new fractures. Results. A total of 123 (74% female) underwent PV for 163 VCFs. Eleven patients did not complete final follow-up at 2 years due to death unrelated to the PV procedure. The mean VAS score was 7.6 at baseline and 3.1 at 30 minutes after the procedure, and 2.3, 1.2, 1.1, 0.9, 0.8, and 0.5 at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years, respectively. Improvement over time was statistically significant using repeated measures analysis of variance (P < 0.05). No complications were encountered during the follow-up intervals. Thirteen new fractures were observed (10.6%) at a mean 20.8 weeks (1-52 weeks) after PV with 6 new fractures (4.9%) involving an adjacent level in 5 patients (4.1%). Conclusion. Vertebroplasty for VCFs in the very elderly appears effective and safe without increased risk of adjacent level fracture.

AB - Study Design. A prospective observational cohort study of consecutive osteoporotic vertebral compression fractures (VCFs) in ≥90-year-old patients evaluated at a multidisciplinary, university spine center. Objective. Assess efficacy, safety, and new fracture occurrence after percutaneous vertebroplasty (PV) in a large uncontrolled cohort of ultra elderly VCF patients. Summary Of Background Data. VCFs are associated with increased morbidity and mortality. Percutaneous injection of polymethylmethacryl-ate into the fractured vertebral body, vertebroplasty, has been extensively performed as an effective minimally-invasive treatment option for VCF patients. The patient sample included consecutive, osteoporotic patients with symptomatic VCFs electing to enter the study. Methods. Baseline visual analogue scale rating, analgesic usage, duration of symptoms. Subsequent VAS ratings, analgesic utilization, and new fractures were assessed within 30 minutes after the procedure, at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years postprocedure. Outcome measures: Visual Analogue Scale score, analgesic utilization, patient satisfaction, cement extravasation, and new fractures. Results. A total of 123 (74% female) underwent PV for 163 VCFs. Eleven patients did not complete final follow-up at 2 years due to death unrelated to the PV procedure. The mean VAS score was 7.6 at baseline and 3.1 at 30 minutes after the procedure, and 2.3, 1.2, 1.1, 0.9, 0.8, and 0.5 at 2 weeks, 1 month, 3 months, 6 months, 1 year, and 2 years, respectively. Improvement over time was statistically significant using repeated measures analysis of variance (P < 0.05). No complications were encountered during the follow-up intervals. Thirteen new fractures were observed (10.6%) at a mean 20.8 weeks (1-52 weeks) after PV with 6 new fractures (4.9%) involving an adjacent level in 5 patients (4.1%). Conclusion. Vertebroplasty for VCFs in the very elderly appears effective and safe without increased risk of adjacent level fracture.

KW - low back pain

KW - osteoporosis

KW - recurrent fracture

KW - vertebral fracture

KW - vertebroplasty

UR - http://www.scopus.com/inward/record.url?scp=79951773048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951773048&partnerID=8YFLogxK

U2 - 10.1097/BRS.0b013e3181cf8a37

DO - 10.1097/BRS.0b013e3181cf8a37

M3 - Article

C2 - 20975625

AN - SCOPUS:79951773048

VL - 36

SP - 277

EP - 282

JO - Spine

JF - Spine

SN - 0362-2436

IS - 4

ER -